CHICAGO – The Pancreatic Cancer Action Network (PanCAN) said Thursday that it has chosen Seven Bridges to build a customized health data platform to support pancreatic cancer research.
This platform will integrate longitudinal multiomic molecular, clinical, and outcomes data generated through PanCAN's research and clinical programs and serve as a hub for researchers to collaborate on analyses to inform drug discovery, according to Boston-based Seven Bridges. Data will be deidentified to satisfy regulatory requirements, the company said.